Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
134
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Drug-Resistant TB, HIV and COVID-19 Co-Infection: Case Reviews from Kwa-Zulu Natal, South Africa

Razia Hassan-Moosa1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa;2 MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South AfricaORCID Iconhttps://orcid.org/0000-0001-8231-7076View further author information
ORCID Icon,
Kegaugetswe Wilhemina Motsomi1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South AfricaCorrespondence[email protected]
View further author information
,
Radhamoney Narasimmulu1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South AfricaView further author information
,
Aida Sivro1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa;3 Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa;4 JC Wilt Infectious Disease Research Centre, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada;5 Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, CanadaView further author information
,
Kevindra K Naidu1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South AfricaView further author information
,
Ayesha BM Kharsany1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa;3 Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South AfricaORCID Iconhttps://orcid.org/0000-0001-7457-0194View further author information
ORCID Icon,
Natasha Samsunder1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South AfricaView further author information
,
Rubeshan Perumal1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa;2 MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South AfricaView further author information
&
Kogieleum Naidoo1 Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa;2 MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South AfricaORCID Iconhttps://orcid.org/0000-0002-8874-6661View further author information
ORCID Icon show all
Pages 7663-7670 | Received 05 Aug 2023, Accepted 29 Nov 2023, Published online: 15 Dec 2023

References

  • World Health Organization. WHO global TB report 2022; 2022.
  • Visca D, Ong C, Tiberi S, et al. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 2021;27(2):151–165. doi:10.1016/j.pulmoe.2020.12.012
  • Kumar M, Surendran D, Manu M, Rakesh P, Balakrishnan S. Mortality due to TB-COVID-19 coinfection in India. Int J Tuberc Lung Dis. 2021;25(3):250–251. doi:10.5588/ijtld.20.0947
  • Gao Y, Liu M, Chen Y, Shi S, Geng J, Tian J. Association between tuberculosis and COVID‐19 severity and mortality: a rapid systematic review and meta‐analysis. J Med Virol. 2021;93(1):194. doi:10.1002/jmv.26311
  • Bertagnolio S, Thwin SS, Silva R, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO global clinical platform of COVID-19. Lancet HIV. 2022;9(7):e486–e95. doi:10.1016/S2352-3018(22)00097-2
  • Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases SA. Risk factors for Coronavirus Disease 2019 (COVID-19) death in a Population Cohort Study from the Western Cape Province, South Africa. Clin Infect Dis. 2020;73(7):e2005–e2015.
  • Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J. 2020;56(1):2001708. doi:10.1183/13993003.01708-2020
  • Motta I, Centis R, D’Ambrosio L, et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020;26(4):233–240. doi:10.1016/j.pulmoe.2020.05.002
  • He G, Wu J, Shi J, et al. COVID‐19 in tuberculosis patients: a report of three cases. J Med Virol. 2020;92(10):1802. doi:10.1002/jmv.25943
  • Tham SM, Lim WY, Lee CK, et al. Four patients with COVID-19 and tuberculosis, Singapore, April–May 2020. Emerg Infect Dis. 2020;26(11):2763. doi:10.3201/eid2611.202752
  • Faqihi F, Alharthy A, Noor A, Balshi A, Balhamar A, Karakitsos D. COVID-19 in a patient with active tuberculosis: a rare case-report. Respir Med Case Rep. 2020;31:101146. doi:10.1016/j.rmcr.2020.101146
  • Jassat W, Cohen C, Tempia S, et al. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV. 2021;8(9):e554–e567.
  • Rivas N, Espinoza M, Loban A, et al. Case report: COVID-19 recovery from triple infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2. American JTrop Med Hyg. 2020;103(4):1597. doi:10.4269/ajtmh.20-0756
  • Cooper TJ, Woodward B, Alom S, Harky A. Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review. HIV Med. 2020;21(9):567–577. doi:10.1111/hiv.12911
  • Hoffmann C, Casado JL, Härter G, et al. Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV. HIV Med. 2021;22(5):372–378. doi:10.1111/hiv.13037
  • Karim F, Moosa MY, Gosnell B, et al. Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection. MedRxiv. 2021;2021:1.
  • Cele S, Karim F, Lustig G, et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe. 2022;30(2):154–62. e5. doi:10.1016/j.chom.2022.01.005
  • Ao Z, Li Y, Wei J, et al. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study. Clin Exp Med. 2021;21:361–367. doi:10.1007/s10238-021-00687-y
  • Yousaf Z, Khan AA, Chaudhary HA, et al. Cavitary pulmonary tuberculosis with COVID-19 coinfection. IDCases. 2020;22:e00973. doi:10.1016/j.idcr.2020.e00973

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.